The California Prescription Drug Monitoring Programâ€™s (PDMP) mission is to reduce pharmaceutical drug diversion while promoting legitimate medical practice and patient care. PDMP accumulates Schedule II through IV controlled substance prescription and dispensation information for facilitating diversion awareness and intervention. It is assumed prescribers and pharmacists dedicate their professional skills to identify and assist controlled substance abusers.
Prescribing practitioners and dispensers must treat this information in accordance with the provisions of the Health Insurance Portability and Accountability Act (HIPAA), the California Confidentiality of Medical Information Act, and Health & Safety Code section 11165(c). Law enforcement users must obtain, use and share this information with criminal justice partners only in conjunction with criminal investigative matters. This data shall not be disclosed, sold, or transferred to any third party.
Any other use of this information is strictly prohibited.
Users of the information herein must know, understand, and abide by these provisions.
The Department of Justice (DOJ) limits access and dissemination of this information to licensed prescribers, licensed pharmacists, law enforcement personnel, and regulatory board personnel strictly for patient care or official investigatory/regulatory purposes. DOJ pursues regulatory and/or criminal sanctions for misuse of PDMP information.
Logging into the PDMP system signifies you understand and agree to these terms.
A streamlined application and approval process for
access to the Controlled Substance Utilization Review and Evaluation System (CURES) 2.0 is nearing completion and will become available during Summer 2015.
Prescribers and pharmacists are encouraged
to register for CURES access as soon as possible in observance of new mandates to enroll before
January 1, 2016.